Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Chande, Nilesh ^a   McDonald, J W ^b   MacDonald, J K ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CORTICOSTEROID DERIVATIVE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; REVIPARIN; SALICYLIC ACID DERIVATIVE; TINZAPARIN;

CHI SQUARE TEST; CLINICAL TRIAL; COCHRANE LIBRARY; COLONOSCOPY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; DATA EXTRACTION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EMBASE; HISTOPATHOLOGY; HUMAN; MEDLINE; MEGACOLON; OUTCOME ASSESSMENT; PUBLICATION; QUALITY CONTROL; QUALITY OF LIFE; RATING SCALE; RECTUM HEMORRHAGE; REMISSION; REVIEW; SIGMOIDOSCOPY; SINGLE DRUG DOSE; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 44949191518     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006774.pub2     Document Type: Review

References (42)

1. Bloom 2004 {published data only} Bloom S, Kiilerich S, Lassen M, O'Morain C, Forbes A, Orm S. Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology 2003;124(4 Suppl 1):A67.
2. *Bloom S, Liilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, et al.Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther 2004;19(8):871-8.
3. de Bievre 2007 {published data only} de Bievre MA, Vrij AA, Oberndorff-Klein Woolthuis AH, Hemker HC, Stockbrugger RW. A randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology 2003;124(4 Suppl 1):A68.
4. *de Bievre MA, Vrij AA, Schoon EJ, Dijkstra G, de Jong AE, Oberndorff-Klein AH, et al.Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis 2007;13(6):753-8.
5. Vrij AA, Oberndorff-Klein-Woolthuis A, Dijkstra G, de Jong AE, Wagenvoord R, Hemker HC, et al.Thrombin generation in mesalazine refractory ulcerative colitis and the influence of lowmolecular weight heparin. J Thromb Thrombolysis 2007;24(2):175-82.
6. Panes 2000 {published data only} Panes J, Esteve M, Cabre E, Hinojosa J, Andreu M, Sans M, et al.Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology 2000;119(4):903-8.
7. Zezos 2006 {published data only} Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, et al.Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther 2006;23(10):1443-53.
8. Ang 2000 Ang YS, Mahmud N, White B, Byrne M, Kelly A, Lawler M, et al.Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther 2000;14(8):1015-22.
9. Ashizuka 2006 Ashizuka S, Nishiura R, Ishikawa N, Yamaga J, Inatsu H, Fujimoto S, et al.Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications. Ther Apher Dial 2006;10(1):54-8.
10. Brazier 1996 Brazier F, Yzet T, Boruchowicz A, Colombel JF, Duchmann JC, Dupas JL. Treatment of ulcerative colitis with heparin. Gastroenterology 1996;110(Suppl):A782.
11. Cui 1999 Cui HF, Jiang XL. Treatment of corticosteroid -resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol 1999;5(5):448-50.
12. Dotan 2001 Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, et al.Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci 2001;46(10):2239-44.
13. Evans 1997 Evans RC, Wong VS, Morris AI, Rhodes JM. Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 1997;11(6):1037-40.
14. Folwaczny 1995 Folwaczny C, Fricke H, Spannagl M, Loeschke K. Heparin for therapy of ulcerative colitis: therapy of a concomitant phenomenon or indication of pathophysiology?. Z Gastroenterol 1995;33(12): 723-4.
15. Folwaczny 1997 Folwaczny C, Fricke H, Endres S, Hartmann G, Jochum M, Loeschke K. Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol 1997;92(5):911-2.
16. Folwaczny 1999 Folwaczny C, Wiebecke B, Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999;94(6):1551-5.
17. Gaffney 1991 Gaffney PR, O'Leary JJ, Doyle CT, Gaffney A, Hogan J, Smew F, et al.Response to heparin in patients with ulcerative colitis. Lancet 1991;337(8735):238-9.
18. Gaffney 1995 Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995;90(2):220-3.
19. Ikehata 2003 Ikehata A, Yamakawa M, Kitagawa M, Fujiwara T, Miura T, Ono S, et al.A case of refractory ulcerative colitis treated successfully with a combination of low-dose heparin and 5-aminosalicylic acid. Nippon Shokakibyo Gakkai Zasshi 2003;100(5):567-71.
20. Korzenik 1999 Korzenik JR, Robert ME, Bitton A, Robinson M, Scherl EJ, Fisher RL, et al.A multicenter, randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterology 1999;116(4 Part 2):A752.
21. Korzenik 2003 Korzenik J, Miner P, Stanton D, Issacs K, Zimmerman E, Riff D, et al.Multicenter, randomized, double-blind, placebo-controlled trial of deligoparin (ultra low molecular weight heparin) for active ulcerative colitis. Gastroenterology 2003;124(4 Suppl 1):A67.
22. Matsuzaki 2001 Matsuzaki T, Nakazawa T, Nakazawa A, Otsuka S, Maeda N, Yonei Y, et al.A case of ulcerative colitis (proctitis type) complicated with deep venous thrombosis and treated with heparin successfully. Nippon Shokakibyo Gakkai Zasshi 2001;98(3):300-6.
23. Miyake 1998 Miyake Y, Suwaki K, Fujimoto T, Hirohata M. Two cases of intractable ulcerative colitis with successful heparin treatment. Nippon Shokakibyo Gakkai Zasshi 1998;95(9):1027-31.
24. Saibeni 2006 Saibeni S, Spina L, Signorelli C, Pastorelli L, de Franchis R, Moro L, et al.Safety and efficacy of oral, colonic-release, low molecular weight heparin-MMX for the treatment of mild to moderate left-sided ulcerative colitis: preliminary report of a pilot study. Gastroenterology 2006;130(4 Suppl 2):A662.
25. Torkvist 1998 Torkvist L, Thorlacius H, Lapidus A, Sjoqvist U, Flood L, Agren B, et al.Low molecular weight heparin as adjuvant therapy in ulcerative colitis. Gastroenterology 1998;114(4 Part 2):A1112-3.
26. Torkvist 1999 Torkvist L, Thorlacius H, Sjoqvist U, Bohman L, Lapidus A, Flood L, et al.Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 1999;13(10): 1323-8.
27. Torkvist 2001 Torkvist L, Stahlberg D, Bohman L, Sjoqvist U, Loof L, Jarnerot G, et al.LMWH for the treatment of mild to moderately active steroid refractory/dependent UC - An independent, multicenter, randomised, controlled study. Gastroenterology 2001;120(5 Suppl 1):A277.
28. Vrij 2001 Vrij AA, Jansen JM, Schoon EJ, de Bruine A, Hemker HC, Stockbrugger RW. Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence onmucosal capillary thrombi. Scand J Gastroenterol Suppl 2001, (234):41-7.
29. Zavgorodnii 1982 Zavgorodnii LG, Mustiats AP. Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis [Primenenie antikoaguliantov v kompleksnom lechenii nespetsificheskogo iazvennogo kolita]. Klin Med (Mosk) 1982;60(6):74-80.
30. Zhernakova 1984 Zhernalova TV, Kashmenskaia NA, Mal'tseva IV, Prigozhina VK, Fomin IA. Hemostasis and heparin therapy in nonspecific ulcerative colitis. Sov Med 1984, (2):110-3.
31. Ardizzone 2006 Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55(1):47-53.
32. Bernstein 2001 Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolismamong patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001;85(3):430-4.
33. Dhillon 1992 Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al.Mucosal capillary thrombi in rectal biopsies. Histopathology 1992;21(2):127-33.
34. Hawthorne 1992 Hawthorne AB, Logan RF, Hawkey CJ, Foster PN, Axon AT, Swarbrick ET, et al.Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305(6844):20-2.
35. Hudson 1996 Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996;38(5):733-7.
36. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized trials: is blinding necessary?. Control Clin Trials 1996;17(1):1-12.
37. Jewell 1974 Jewell DP, Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974;4(5945):627-30.
38. Lawson 2006 Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD005112. DOI:10.1002/14651858.CD005112.pub2.
39. Rutgeerts 2005 Rutgeerts P, Sandborn B, Feagan BG, Reinisch W, Olson A, Johanns J, et al.Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353(23):2462-76.
40. Shibolet 2005 Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database of Systematic Reviews 2005, Issue 1.Art. No.: CD004277. DOI:10.1002/14651858.CD004277.pub2.
41. Souto 1995 Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, et al.Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995;40(9):1883-9.
42. Timmer 2007 Timmer A, McDonald JW, MacDonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD000478. DOI:10.1002/14651858.CD000478.pub2.